Literature DB >> 18716967

Bilateral infiltrative disease of the extraocular muscles: a rare clinical presentation of early stage chronic lymphocytic leukemia.

Yashin D Ramkissoon1, Richard W J Lee, Rizwan Malik, James D Hsuan, Mike J Potts.   

Abstract

Orbital involvement in chronic lymphocytic leukemia (CLL) is highly unusual and most commonly involves hemorrhage or soft tissue infiltration in advanced disease. We report a case of rapid onset bilateral orbital muscle infiltration as the presenting feature of early stage CLL. In addition, we demonstrate clinico-pathological correlation with an identical chronic B-cell lymphocytic infiltrate in both orbit and bone marrow, with good response of the orbital disease to local radiotherapy.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18716967     DOI: 10.1080/01676830802222878

Source DB:  PubMed          Journal:  Orbit        ISSN: 0167-6830


  4 in total

1.  Intramuscular leukemic relapse: clinical signs and imaging findings. A multicentric analysis.

Authors:  Alexey Surov; Hayyam Kiratli; Soo Ah Im; Yasuhiro Manabe; Alibhe O'Neill; Atul B Shinagare; Rolf Peter Spielmann
Journal:  Skeletal Radiol       Date:  2014-09-26       Impact factor: 2.199

2.  Rare primary presentation of chronic lymphocytic leukemia as chronic orbital space occupying lesion.

Authors:  Vaibhav Kumar Jain; Usha Singh; Gaurav Prakash; Rakesh Kumar Vashishta; Vaneet Singh
Journal:  Int J Ophthalmol       Date:  2016-01-18       Impact factor: 1.779

3.  Chronic lymphocytic leukemia presenting as unilateral extraocular muscle enlargement and proptosis.

Authors:  Amun Sachdev; Nigel Timothy O'Connor; Suresh Reddy Sagili
Journal:  Oman J Ophthalmol       Date:  2018 Jan-Apr

4.  CLL: Common Leukemia; Uncommon Presentations.

Authors:  Deepesh Lad; Pankaj Malhotra; Neelam Varma; Manupdesh Singh Sachdeva; Ashim Das; Radhika Srinivasan; Amanjit Bal; Alka Khadwal; Gaurav Prakash; Vikas Suri; Savita Kumari; Sanjay Jain; Subhash Varma
Journal:  Indian J Hematol Blood Transfus       Date:  2014-12-24       Impact factor: 0.900

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.